Home > Publications Database > Immuncheckpointinhibitoren in der Behandlung der progressiven multifokalen Leukenzephalopathie. > print

001     162925
005     20240320115515.0
024 7 _ |a pmc:PMC9200684
|2 pmc
024 7 _ |a 10.1007/s00115-021-01194-x
|2 doi
024 7 _ |a pmid:34586433
|2 pmid
024 7 _ |a 0028-2804
|2 ISSN
024 7 _ |a 1433-0407
|2 ISSN
037 _ _ |a DZNE-2021-01577
041 _ _ |a German
082 _ _ |a 610
100 1 _ |a Nitsch, L.
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a Immuncheckpointinhibitoren in der Behandlung der progressiven multifokalen Leukenzephalopathie.
260 _ _ |a Heidelberg
|c 2022
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1657544991_30474
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a (CC BY)
520 _ _ |a Die progressive multifokale Leukenzephalopathie (PML) ist eine meist verheerend verlaufende ZNS-Infektion, die durch das John-Cunningham(JC)-Virus verursacht wird. Die hier dargestellte Fallserie beschreibt die unterschiedlichen Verläufe einer PML und die Möglichkeit, Immuncheckpointinhibitoren in der Behandlung der PML einzusetzen.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 2 |a Antineoplastic Agents, Immunological
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Immune Checkpoint Inhibitors
|2 MeSH
650 _ 2 |a Leukoencephalopathy, Progressive Multifocal: diagnosis
|2 MeSH
650 _ 2 |a Leukoencephalopathy, Progressive Multifocal: drug therapy
|2 MeSH
650 _ 2 |a Magnetic Resonance Imaging
|2 MeSH
700 1 _ |a Kaps, V.
|b 1
700 1 _ |a Zschernack, V.
|b 2
700 1 _ |a Gancarczyk, N.
|b 3
700 1 _ |a van Essen, F.
|b 4
700 1 _ |a Schmeel, Frederic Carsten
|0 P:(DE-2719)9001551
|b 5
|u dzne
700 1 _ |a Klockgether, T.
|0 P:(DE-2719)2810314
|b 6
|u dzne
700 1 _ |a Zimmermann, J.
|b 7
700 1 _ |a Müller, M.
|0 P:(DE-HGF)0
|b 8
773 _ _ |a 10.1007/s00115-021-01194-x
|0 PERI:(DE-600)1462945-8
|n 6
|p 624-628
|t Der Nervenarzt
|v 93
|y 2022
|x 1433-0407
856 4 _ |u https://link.springer.com/article/10.1007%2Fs00115-021-01194-x
856 4 _ |u https://pub.dzne.de/record/162925/files/DZNE-2021-01577.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/162925/files/DZNE-2021-01577.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:162925
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 5
|6 P:(DE-2719)9001551
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2810314
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2022
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-12
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NERVENARZT : 2021
|d 2022-11-12
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-28
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2021-01-28
|w ger
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-12
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-12
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-12
920 1 _ |0 I:(DE-2719)1011001
|k AG Klockgether
|l Clinical Research- coordination
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1011001
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21